2-(2-Pyridylamino)ethanthiol | 1822-55-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(2-Pyridylamino)ethanthiol
• 英文别名: 2-pyridin-2-ylamino-ethanethiol；2-(2-Pyridinylamino)ethanethiol；2-(pyridin-2-ylamino)ethanethiol
• CAS: 1822-55-5
• 化学式: C₇H₁₀N₂S
• 分子量: 154.236
• InChiKey: LJMHQLKVDBYDBF-UHFFFAOYSA-N

物化性质

• 沸点：
  116-117 °C(Press: 1 Torr)
• 密度：
  1.162±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  25.9
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Cross-linked star-shaped self-assembled polypeptides and its use as carriers in biomedical applications
  申请人：CENTRO DE INVESTIGACION PRINCIPE FELIPE

  公开号：US10155050B2

  公开（公告）日：2018-12-18

  The invention relates to 3-arms star-shaped polypeptides derivatives which are able to self-assemble to form bioresponsive nanometric globular structures with controllable size and shape. These multivalent constructs also present the ability of disassemble under specific physiological conditions and of linking to at least one active agent so that they can be used as carries in biomedical applications.

  本发明涉及三臂星形多肽衍生物，这些衍生物能够自我组装，形成大小和形状可控的生物反应性纳米球状结构。这些多价结构还具有在特定生理条件下分解的能力，并能与至少一种活性剂连接，因此可用作生物医学应用中的载体。
• CROSS-LINKED STAR-SHAPED SELF-ASSEMBLED POLYPEPTIDES AND ITS USE AS CARRIERS IN BIOMEDICAL APPLICATIONS
  申请人：Centro Investigacion Principe Felipe

  公开号：EP3331937A1

  公开（公告）日：2018-06-13
• [EN] CROSS-LINKED STAR-SHAPED SELF-ASSEMBLED POLYPEPTIDES AND ITS USE AS CARRIERS IN BIOMEDICAL APPLICATIONS<br/>[FR] POLYPEPTIDES AUTO-ASSEMBLÉS, RÉTICULÉS, EN FORME D'ÉTOILE ET LEUR UTILISATION EN TANT QUE SUPPORTS DANS DES APPLICATIONS BIOMÉDICALES
  申请人：CENTRO DE INVESTIG PRINCIPE FELIPE

  公开号：WO2017025298A1

  公开（公告）日：2017-02-16

  The invention relates to 3-arms star-shaped polypeptides derivatives which are able to self-assemble to form bioresponsive nanometric globular structures with controllable size and shape. These multivalent constructs also present the ability of disassemble under specific physiological conditions and of linking to at least one active agent so that they can be used as carries in biomedical applications.